Dato-DXd

Dato-DXd

CNS activity and sequencing strategies for Dato-DXd in EGFR-mutated NSCLC featuring expert oncologists from OncUpdates.

Dato-DXd

01/14/2026

Ep. 5: CNS Activity and Sequencing Strategies for Datopotamab Deruxtecan in EGFR-Mutant NSCLC

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncologists Dr. Aaron Lisberg, Dr. Sarah Sunshine, Dr. Blanca Ledezma, Dr. Rahul Gosain, and Dr. Rohit Gosain discuss Dato-DXd in EGFR-Mutant NSCLC for community-based monitoring and toxicity management.

Dato-DXd

01/13/2026

Ep. 4: Datopotamab Deruxtecan in EGFR-Mutated NSCLC: Community-Based Monitoring and Toxicity Management

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncology researchers discussing monitoring, dosing, and rechallenge strategies in EGFR-mutated NSCLC during a conference panel.

Dato-DXd

01/12/2026

EP. 3: Monitoring, Dosing, and Rechallenge Strategies With Datopotamab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncology panel discussing practical strategies for managing ocular, oral, and pulmonary toxicities with Dato-DXd in cancer treatment.

Dato-DXd

01/11/2026

Ep. 2: Managing Ocular Toxicity, Mucositis, and ILD With Datopotamab Deruxtecan in EGFR-Mutated NSCLC

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Team of medical researchers and oncologists discussing efficacy, safety, and management of data-driven targeted therapy (DAtDX) in EGFR-mutated lung cancer.

Dato-DXd

01/09/2026

Ep. 1: Efficacy, Safety, and Management of Dato-DXd in EGFR-Mutated Lung Cancer

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert medical team discussing clinical insights on Dato-DXd in EGFR-mutated NSCLC for oncology research and treatment advancements.

Dato-DXd

12/31/2025

Multidisciplinary Strategies for Dato-DXd in Pretreated EGFR-Mutated Advanced NSCLC (Full Video)

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD